# US 9,428,470 B2 · Heterocyclic compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 9,428,470 B2
- Document ID: US9428470B2
- Status: Granted
- Kind: B2
- Application number: 14/619,464
- Filed: 2015-02-11
- Published: 2015-08-13
- Granted: 2016-08-30
- Earliest claimed: 2014-02-13
- Assignees: Takeda Pharmaceutical Company Limited
- Applicants: Takeda Pharmaceutical Company Limited
- Inventors: Zenichi Ikeda; Minoru Sasaki; Keiko Kakegawa; Fumiaki Kikuchi; Yoichi Nishikawa
- Web page: https://patentgrep.com/patent/US9428470B2

## CPC

- C07D 261/04: having one double bond between ring members or between a ring member and a non-ring member
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 413/10: linked by a carbon chain containing aromatic rings
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the following formula (I): wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.

## Claims

### Claim 1

A compound which is (5R)-3-(3-((4-Carbamimidamidobenzoyl)oxy)phenyl)-5-(carboxymethyl)-4, 5-dihydro-1,2-oxazole-5-carboxylic acid or a salt thereof.

### Claim 2

A compound which is (5S)-3-(3-((4-Carbamimidamidobenzoyl)oxy)phenyl)-5-(carboxymethyl)-4, 5-dihydro-1,2-oxazole-5-carboxylic acid or a salt thereof.

### Claim 3

A compound which is 2,2′-(3-(3-((4-Carbamimidamidobenzoyl)oxy)phenyl)-4,5-dihydro-1,2-oxazole-5,5-diyl)diacetic acid or a salt thereof.
